According to Anavex Life Sciences
's latest financial reports the company has C$0.15 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-09-30 | $C$0.16 B | -15.73% |
2023-09-30 | $C$0.19 B | -1.06% |
2022-09-30 | $C$0.19 B | 1.3% |
2021-09-30 | $C$0.19 B | 427.67% |
2020-09-30 | $C$36.45 M | 35.75% |
2019-09-30 | $C$26.85 M | -6.87% |
2018-09-30 | $C$28.83 M | -4.16% |
2017-09-30 | $C$30.08 M | 262.62% |
2016-09-30 | $C$8.29 M | -51.73% |
2015-09-30 | $C$17.18 M | 7895.98% |
2014-09-30 | $C$0.21 M | -108.46% |
2013-09-30 | $-C$2.55 Million | -10.15% |
2012-09-30 | $-C$2.83 Million | 138.55% |
2011-09-30 | $-C$1.19 Million | -61.2% |
2010-09-30 | $-C$3.06 Million | -25.9% |
2009-09-30 | $-C$4.13 Million | 69.13% |
2008-09-30 | $-C$2.44 Million | 425.45% |
2007-09-30 | $-C$0.47 Million | 2577.8% |
2006-09-30 | $-C$0.02 Million | -42.75% |
2005-09-30 | $-C$0.04 Million | -193.67% |
2004-09-30 | $C$0.03 M |